Status:
COMPLETED
Glutaminergic Agents for Cocaine Abuse - 5
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to evaluate glutaminergic agents for cocaine abuse.
Eligibility Criteria
Please contact site for information.
Key Trial Info
Start Date :
September 1 1994
Trial Type :
INTERVENTIONAL
End Date :
August 1 1999
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000280
Start Date
September 1 1994
End Date
August 1 1999
Last Update
April 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06519